Isame

Irbesartan, the active ingredient in Isame, is an Angiotensin II receptor blocker presented as an oral tablet for oral use. It is employed to lower blood pressure and protect kidney function in patients with hypertension, diabetic nephropathy, and heart failure.

GNH USA supplies Isame as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Irbesartan is used to manage conditions related to the renin‑angiotensin system.

Hypertension: reduces systolic and diastolic blood pressure, decreasing cardiovascular risk. Diabetic nephropathy: slows progression of renal impairment in patients with type 2 diabetes. Heart failure: improves symptoms and reduces hospitalisation in patients with left‑ventricular dysfunction.

Irbesartan may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Headache: mild to moderate pain in the head. - Fatigue: feeling unusually tired. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Hyperkalemia: elevated blood potassium that can affect heart rhythm. - Angioedema: swelling of face, lips, tongue or throat, potentially compromising airway. - Renal impairment: sudden decrease in kidney function, indicated by rising creatinine.

When prescribing Irbesartan, clinicians should consider several precautionary measures to ensure safe use.

- Monitor blood pressure: check regularly to avoid hypotension. - Assess renal function: evaluate serum creatinine and eGFR before and during therapy. - Check serum potassium: avoid hyperkalemia, especially with potassium‑sparing agents. - Use caution in elderly: increased sensitivity to blood‑pressure lowering effects. - Avoid in pregnancy: drug is contraindicated due to fetal toxicity (Category D). - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Irbesartan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - ACE inhibitors or other ARBs: additive effect on blood pressure and potassium, may cause renal dysfunction. - Aliskiren (in diabetes): increased risk of hypotension, hyperkalemia, and renal impairment.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may reduce antihypertensive effect and impair renal function. - Lithium: increased lithium levels, risk of toxicity. - Diuretics (thiazides): may enhance potassium loss, requiring monitoring.